CJC1295 without DAC

CJC-1295 without DAC – Short-Acting GHRH Analogue Research Peptide

CJC-1295 without DAC is a synthetic Growth Hormone–Releasing Hormone (GHRH) analogue
designed to stimulate the release of growth hormone (GH) via the GHRH receptor.
Unlike the DAC-modified variant, this peptide has a shorter half-life, allowing researchers
to study the acute and physiological pulsatile secretion of growth hormone
under in-vitro conditions.

CJC-1295 without DAC is manufactured according to high laboratory standards and verified using
High-Performance Liquid Chromatography (HPLC) to ensure a purity of
≥ 99%. The product is supplied exclusively for controlled
endocrinological and biochemical research applications.

Key specifications

Application & use (research only)

• Intended exclusively for in-vitro research purposes.
• Not suitable for human or veterinary consumption or medical use.
• Applicable to endocrinological and biochemical research on growth hormone regulation and receptor activation.
• Lyophilized form supports stable storage and controlled laboratory handling.